
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $159.3M | $155.3M | $175.2M | $197.2M | $209.8M | |
Revenue Growth (YoY) | -14.01% | -2.52% | 12.77% | 12.61% | 6.39% | |
Cost of Revenues | $15.1M | $15.4M | $15.5M | $13.3M | $12.9M | |
Gross Profit | $144.3M | $139.9M | $159.7M | $184M | $196.9M | |
Gross Profit Margin | 90.55% | 90.09% | 91.16% | 93.27% | 93.84% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $19.7M | $21.5M | $23.7M | $24.3M | $27.2M | |
Other Inc / (Exp) | $39.9M | $4.4M | $35.1M | $21.9M | $2.6M | |
Operating Expenses | $58.8M | $60.8M | $62.7M | $67.4M | $64.4M | |
Operating Income | $85.5M | $79.2M | $96.9M | $116.6M | $132.6M | |
Net Interest Expenses | $29.7M | $27.4M | $31.4M | $47M | $40.3M | |
EBT. Incl. Unusual Items | $95.7M | $56.2M | $100.6M | $91.5M | $94.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $95.7M | $56.2M | $100.6M | $91.5M | $94.9M | |
Minority Interest in Earnings | -$384K | -$363K | -$560K | -$1.7M | -$3.8M | |
Net Income to Common Excl Extra Items | $95.3M | $55.9M | $100M | $89.7M | $91M | |
Basic EPS (Cont. Ops) | $2.42 | $1.41 | $2.49 | $2.16 | $2.07 | |
Diluted EPS (Cont. Ops) | $2.42 | $1.41 | $2.48 | $2.16 | $2.04 | |
Weighted Average Basic Share | $39.2M | $39.2M | $39.9M | $41.3M | $43.7M | |
Weighted Average Diluted Share | $39.3M | $39.2M | $40.1M | $41.4M | $44.2M | |
EBITDA | $164.5M | $121.9M | $169.5M | $175.9M | $171.6M | |
EBIT | $125.4M | $83.6M | $132M | $138.5M | $135.2M | |
Revenue (Reported) | $159.3M | $155.3M | $175.2M | $197.2M | $209.8M | |
Operating Income (Reported) | $85.5M | $79.2M | $96.9M | $116.6M | $132.6M | |
Operating Income (Adjusted) | $125.4M | $83.6M | $132M | $138.5M | $135.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $40.3M | $40.8M | $49.5M | $51.4M | $49M | |
Revenue Growth (YoY) | -13.21% | 1.26% | 21.36% | 3.77% | -4.55% | |
Cost of Revenues | $4M | $4M | $3.3M | $3.4M | $3.1M | |
Gross Profit | $36.3M | $36.8M | $46.2M | $48M | $45.9M | |
Gross Profit Margin | 90.12% | 90.24% | 93.35% | 93.41% | 93.66% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5M | $5.8M | $6.3M | $6.5M | $7M | |
Other Inc / (Exp) | -$576K | $445K | $15.2M | $3.4M | $3.4M | |
Operating Expenses | $14.9M | $15.6M | $17.2M | $15.6M | $19.2M | |
Operating Income | $21.4M | $21.2M | $29M | $32.4M | $26.7M | |
Net Interest Expenses | $7M | $7.1M | $10.6M | $11M | $7.9M | |
EBT. Incl. Unusual Items | $13.9M | $14.5M | $33.6M | $24.7M | $22.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $13.9M | $14.5M | $33.6M | $24.7M | $22.2M | |
Minority Interest in Earnings | -$88K | -$95K | -$427K | -$459K | -$1.5M | |
Net Income to Common Excl Extra Items | $13.8M | $14.4M | $33.1M | $24.2M | $20.7M | |
Basic EPS (Cont. Ops) | $0.35 | $0.36 | $0.80 | $0.56 | $0.45 | |
Diluted EPS (Cont. Ops) | $0.35 | $0.36 | $0.80 | $0.56 | $0.45 | |
Weighted Average Basic Share | $39.1M | $39.2M | $41.1M | $42.9M | $45.3M | |
Weighted Average Diluted Share | $39.2M | $39.3M | $41.2M | $43M | $45.7M | |
EBITDA | $30.7M | $31.1M | $53.4M | $44.8M | $39.3M | |
EBIT | $20.8M | $21.7M | $44.2M | $35.7M | $30.1M | |
Revenue (Reported) | $40.3M | $40.8M | $49.5M | $51.4M | $49M | |
Operating Income (Reported) | $21.4M | $21.2M | $29M | $32.4M | $26.7M | |
Operating Income (Adjusted) | $20.8M | $21.7M | $44.2M | $35.7M | $30.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $153.2M | $155.8M | $183.9M | $199.1M | $207.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $14.8M | $15.4M | $14.8M | $13.4M | $12.7M | |
Gross Profit | $138.4M | $140.4M | $169.1M | $185.8M | $194.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $19.6M | $22.2M | $24.2M | $24.5M | $27.7M | |
Other Inc / (Exp) | -$4.7M | $5.5M | $49.8M | $10M | $2.7M | |
Operating Expenses | $58.9M | $61.5M | $64.4M | $65.8M | $67.9M | |
Operating Income | $79.5M | $79M | $104.7M | $120M | $126.9M | |
Net Interest Expenses | $29M | $27.5M | $34.9M | $47.5M | $37.2M | |
EBT. Incl. Unusual Items | $45.8M | $56.9M | $119.6M | $82.6M | $92.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $45.8M | $56.9M | $119.6M | $82.6M | $92.4M | |
Minority Interest in Earnings | -$383K | -$370K | -$892K | -$1.8M | -$4.9M | |
Net Income to Common Excl Extra Items | $45.4M | $56.5M | $118.7M | $80.8M | $87.5M | |
Basic EPS (Cont. Ops) | $1.16 | $1.42 | $2.94 | $1.92 | $1.95 | |
Diluted EPS (Cont. Ops) | $1.16 | $1.42 | $2.92 | $1.92 | $1.94 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $114.1M | $122.3M | $191.8M | $167.3M | $166M | |
EBIT | $74.8M | $84.4M | $154.5M | $130M | $129.6M | |
Revenue (Reported) | $153.2M | $155.8M | $183.9M | $199.1M | $207.5M | |
Operating Income (Reported) | $79.5M | $79M | $104.7M | $120M | $126.9M | |
Operating Income (Adjusted) | $74.8M | $84.4M | $154.5M | $130M | $129.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $40.3M | $40.8M | $49.5M | $51.4M | $49M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $4M | $4M | $3.3M | $3.4M | $3.1M | |
Gross Profit | $36.3M | $36.8M | $46.2M | $48M | $45.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5M | $5.8M | $6.3M | $6.5M | $7M | |
Other Inc / (Exp) | -$576K | $445K | $15.2M | $3.4M | $3.4M | |
Operating Expenses | $14.9M | $15.6M | $17.2M | $15.6M | $19.2M | |
Operating Income | $21.4M | $21.2M | $29M | $32.4M | $26.7M | |
Net Interest Expenses | $7M | $7.1M | $10.6M | $11M | $7.9M | |
EBT. Incl. Unusual Items | $13.9M | $14.5M | $33.6M | $24.7M | $22.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $13.9M | $14.5M | $33.6M | $24.7M | $22.2M | |
Minority Interest in Earnings | -$88K | -$95K | -$427K | -$459K | -$1.5M | |
Net Income to Common Excl Extra Items | $13.8M | $14.4M | $33.1M | $24.2M | $20.7M | |
Basic EPS (Cont. Ops) | $0.35 | $0.36 | $0.80 | $0.56 | $0.45 | |
Diluted EPS (Cont. Ops) | $0.35 | $0.36 | $0.80 | $0.56 | $0.45 | |
Weighted Average Basic Share | $39.1M | $39.2M | $41.1M | $42.9M | $45.3M | |
Weighted Average Diluted Share | $39.2M | $39.3M | $41.2M | $43M | $45.7M | |
EBITDA | $30.7M | $31.1M | $53.4M | $44.8M | $39.3M | |
EBIT | $20.8M | $21.7M | $44.2M | $35.7M | $30.1M | |
Revenue (Reported) | $40.3M | $40.8M | $49.5M | $51.4M | $49M | |
Operating Income (Reported) | $21.4M | $21.2M | $29M | $32.4M | $26.7M | |
Operating Income (Adjusted) | $20.8M | $21.7M | $44.2M | $35.7M | $30.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $7.8M | $5.2M | $10.4M | $20.3M | $9.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $24.5M | $24.1M | $21.8M | $19.6M | $21.5M | |
Inventory | -- | -- | $10.7M | $18.4M | $670K | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $5.3M | $4.2M | $11.1M | $16M | $15.9M | |
Total Current Assets | $342M | $448.5M | $625.9M | $864.6M | $829M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | $11.3M | $19.3M | $19.3M | $19.3M | $30.6M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $2.5M | -- | -- | -- | -- | |
Total Assets | $1.5B | $1.5B | $1.7B | $1.9B | $1.8B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | $34.3M | $37M | $37.9M | $47.5M | $48.5M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $34.3M | $37M | $37.9M | $349.8M | $192.9M | |
Long-Term Debt | $649.4M | $722.7M | $767.9M | $589.1M | $540.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $683.7M | $759.7M | $805.8M | $938.8M | $733.1M | |
Common Stock | $392K | $394K | $412K | $430K | $455K | |
Other Common Equity Adj | -- | -$172K | $8.7M | $6.1M | $3.8M | |
Common Equity | $767.4M | $736.7M | $828.4M | $881.3M | $960.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $8.4M | $8.4M | $21.9M | $35M | $92.4M | |
Total Equity | $775.8M | $745.1M | $850.3M | $916.3M | $1.1B | |
Total Liabilities and Equity | $1.5B | $1.5B | $1.7B | $1.9B | $1.8B | |
Cash and Short Terms | $7.8M | $5.2M | $10.4M | $20.3M | $9.4M | |
Total Debt | $649.4M | $722.7M | $767.9M | $891.3M | $684.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $8.2M | $4.4M | $5.5M | $9M | $23.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $24.4M | $23.9M | $21.2M | $19.1M | $20.7M | |
Inventory | $4.5M | $32.3M | $4.1M | $389K | $42.5M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $3.7M | $8.5M | -- | -- | $14.6M | |
Total Current Assets | $346.1M | $518.3M | $774.4M | $824.1M | $882.4M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | $19.3M | $19.3M | $19.3M | $19.3M | $17.6M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $2.3M | $2.3M | $10.9M | $17.2M | -- | |
Total Assets | $1.5B | $1.5B | $1.8B | $1.8B | $1.8B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | $31.1M | $30.7M | $33.2M | $39.3M | $44M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $31.1M | $188.6M | $303.3M | $316.4M | $192.9M | |
Long-Term Debt | $659.4M | $604.9M | $630.9M | $583.2M | $533.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $690.5M | $793.5M | $934.2M | $899.6M | $726.2M | |
Common Stock | $394K | $395K | $413K | $433K | $459K | |
Other Common Equity Adj | -- | $4.7M | $7.4M | $6.5M | $2.9M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $8.4M | $8.4M | $25.8M | $32.6M | $87.4M | |
Total Equity | $764.8M | $742.6M | $864.6M | $918.8M | $1B | |
Total Liabilities and Equity | $1.5B | $1.5B | $1.8B | $1.8B | $1.8B | |
Cash and Short Terms | $8.2M | $4.4M | $5.5M | $9M | $23.3M | |
Total Debt | $659.4M | $762.8M | $901M | $860.2M | $682.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $95.7M | $56.2M | $100.6M | $91.5M | $94.9M | |
Depreciation & Amoritzation | $39.1M | $38.3M | $37.5M | $37.4M | $36.4M | |
Stock-Based Compensation | $7M | $7.8M | $8M | $8.5M | $9.1M | |
Change in Accounts Receivable | -$6.2M | -$6.8M | -$7.2M | -$9.3M | -$10.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $116.1M | $91.2M | $105.6M | $104.4M | $125.2M | |
Capital Expenditures | $354K | -- | -- | -- | -- | |
Cash Acquisitions | $9.3M | -$5.7M | -- | -- | -$11.3M | |
Cash From Investing | $43.9M | -$69.8M | -$119.9M | -$174.9M | $90.7M | |
Dividends Paid (Ex Special Dividend) | -$90.3M | -$90.5M | -$91.5M | -$94.8M | -$100.5M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $24M | $304.4M | $269M | $277.5M | $27.2M | |
Long-Term Debt Repaid | -$68.2M | -$230.6M | -$223.1M | -$154.4M | -$234.3M | |
Repurchase of Common Stock | -$18M | -- | -- | -- | -- | |
Other Financing Activities | -$4.1M | -$7.4M | -$2.5M | -$1.6M | -$1.5M | |
Cash From Financing | -$156.5M | -$24M | $19.6M | $80.4M | -$226.7M | |
Beginning Cash (CF) | $4.2M | $7.8M | $5.2M | $10.4M | $20.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $3.5M | -$2.6M | $5.2M | $9.9M | -$10.9M | |
Ending Cash (CF) | $7.8M | $5.2M | $10.4M | $20.3M | $9.4M | |
Levered Free Cash Flow | $115.7M | $91.2M | $105.6M | $104.4M | $125.2M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $18.3M | $54.5M | $6.6M | $19.7M | -- | |
Depreciation & Amoritzation | $9.5M | $9.4M | $9.4M | $9M | -- | |
Stock-Based Compensation | $2M | $2M | $2.1M | $2.3M | -- | |
Change in Accounts Receivable | -$1.5M | -$1.5M | -$2.5M | -$1.9M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $27.4M | $29.9M | $28.5M | $36.8M | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -$11.2M | -- | |
Cash From Investing | $33.8M | -$10.3M | -$55.2M | -$22.2M | -- | |
Dividends Paid (Ex Special Dividend) | -$22.4M | -$22.6M | -$23.6M | -$24.8M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $127M | $62.3M | $8.9M | -- | |
Long-Term Debt Repaid | -$41M | -$153.9M | -$10M | -$8.2M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$275K | -$2.2M | -$487K | $104K | -- | |
Cash From Financing | -$63.7M | -$17.5M | $28.2M | -$17.5M | -- | |
Beginning Cash (CF) | $8.2M | $4.4M | $5.5M | $9M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$2.5M | $2M | $1.5M | -$2.8M | -- | |
Ending Cash (CF) | $5.7M | $6.4M | $7M | $6.2M | -- | |
Levered Free Cash Flow | $27.4M | $29.9M | $28.5M | $36.8M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $45.8M | $56.9M | $119.6M | $82.6M | $92.4M | |
Depreciation & Amoritzation | $39.3M | $37.9M | $37.3M | $37.3M | $36.4M | |
Stock-Based Compensation | $7.1M | $7.8M | $8.1M | $8.6M | $9.1M | |
Change in Accounts Receivable | -$6.4M | -$6.7M | -$7.6M | -$9.4M | -$11.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $113.5M | $88.5M | $105.1M | $107.4M | $133.7M | |
Capital Expenditures | $163K | -- | -- | -- | -- | |
Cash Acquisitions | $3.7M | -- | -- | -- | $1.7M | |
Cash From Investing | -$11.8M | -$101.2M | -$216.7M | -$21.5M | $81.1M | |
Dividends Paid (Ex Special Dividend) | -$90.3M | -$89.8M | -$92.6M | -$95.8M | -$103.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $17M | $334.4M | $384.7M | $125.1M | $31.9M | |
Long-Term Debt Repaid | -$47.2M | -$230.6M | -$245.7M | -$166.3M | -$210.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$3.9M | -$5.2M | -$3.1M | -$1.8M | -$5.4M | |
Cash From Financing | -$124.4M | $8.9M | $112.8M | -$82.5M | -$200.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$22.7M | -$3.8M | $1.1M | $3.5M | $14.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $113.5M | $88.5M | $105.1M | $107.4M | $133.7M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $32.2M | $69M | $40.2M | $44.4M | $22.2M | |
Depreciation & Amoritzation | $19.4M | $18.8M | $18.6M | $18.1M | $9.2M | |
Stock-Based Compensation | $3.8M | $3.9M | $4.2M | $4.5M | $2.3M | |
Change in Accounts Receivable | -$3.2M | -$3.2M | -$4.6M | -$4.1M | -$3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $48.6M | $48.4M | $46.5M | $57.9M | $29.6M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -$5.7M | -- | -- | -$11.2M | $13M | |
Cash From Investing | $29.8M | -$45.8M | -$187.4M | -$1M | $11.6M | |
Dividends Paid (Ex Special Dividend) | -$45.6M | -$45.1M | -$47.2M | -$49.4M | -$27.3M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $17M | $174M | $225M | $19.2M | $15M | |
Long-Term Debt Repaid | -$48M | -$160.9M | -$39.6M | -$49.7M | -$17.5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$3.8M | -$3.6M | -$2.5M | -$2.1M | -$6M | |
Cash From Financing | -$80.5M | -$1.4M | $137.5M | -$71M | -$27.3M | |
Beginning Cash (CF) | $16M | $9.6M | $15.9M | $29.3M | $9.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$2.1M | $1.2M | -$3.4M | -$14.1M | $13.9M | |
Ending Cash (CF) | $13.9M | $10.8M | $12.6M | $15.2M | $23.3M | |
Levered Free Cash Flow | $48.6M | $48.4M | $46.5M | $57.9M | $29.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.